↓ Skip to main content

Dove Medical Press

Article Metrics

Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, September 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
22 Mendeley
Title
Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?
Published in
ClinicoEconomics and Outcomes Research: CEOR, September 2012
DOI 10.2147/ceor.s35194
Pubmed ID
Authors

Giuliano Rizzardini, Restelli, Bonfanti, Porazzi, Ricci, Foglia, Croce, Carenzi

Abstract

In recent years, the increased efficacy and effectiveness of antiretroviral treatment has led to longer survival of patients infected with human immunodeficiency virus (HIV), but has also raised the question of what happens to consumption of resources. Early highly active antiretroviral treatment (HAART), management of hepatitis C virus (HCV) coinfection, and expensive newly marketed drugs may affect the economic sustainability of treatment from the point of view of the National Healthcare Services. The present study aimed to provide information on the economic burden of HIV-positive patients resident in the Lombardy region using a three-year time horizon.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Professor 5 23%
Other 4 18%
Student > Bachelor 3 14%
Student > Master 3 14%
Researcher 2 9%
Other 1 5%
Unknown 4 18%
Readers by discipline Count As %
Medicine and Dentistry 8 36%
Economics, Econometrics and Finance 3 14%
Agricultural and Biological Sciences 3 14%
Nursing and Health Professions 2 9%
Business, Management and Accounting 1 5%
Other 1 5%
Unknown 4 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 October 2012.
All research outputs
#14,343,493
of 21,338,376 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#317
of 469 outputs
Outputs of similar age
#93,209
of 148,291 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#6
of 10 outputs
Altmetric has tracked 21,338,376 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 469 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 148,291 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.